Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.35 -0.22 (-1.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

32 33 Next >

Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments ↗

December 09, 2022

(Part four of a four-part series) See previous stories:

Via Benzinga

Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗

December 08, 2022

Via Benzinga

Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday ↗

December 08, 2022

U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Psychedelic Stock Gainers And Losers From December 7, 2022 ↗

December 07, 2022

Via Benzinga

Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗

December 06, 2022

Via Benzinga

Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes ↗

November 16, 2022

(Part one of a four-part series)

Via Benzinga

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

December 05, 2022

Via Benzinga

Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD ↗

December 03, 2022

The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and...

Via Talk Markets

Psychedelic Stock Gainers And Losers From December 2, 2022 ↗

December 02, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From December 1, 2022 ↗

December 01, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 30, 2022 ↗

November 30, 2022

Via Benzinga

Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 29, 2022

Via Benzinga

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More ↗

November 29, 2022

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

Via Benzinga

3 Big Trends Shaking Up Psychedelic Stocks ↗

November 29, 2022

Major positive shifts are happening, but the field faces new headwinds too.

Via The Motley Fool

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

November 28, 2022

Via Benzinga

Cannabis Category Performances Last Week Ranged From +5.2% To -2.3% ↗

November 27, 2022

The 5 categories in the cannabis sector perform quite differently week to week and last week was no exception. This article is a summary of how each category performed last week, in descending order...

Via Talk Markets

Psychedelic Stock Gainers And Losers From November 25, 2022 ↗

November 25, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 24, 2022 ↗

November 24, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 23, 2022 ↗

November 23, 2022

Via Benzinga

Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue ↗

November 23, 2022

(Part three of a four-part series) Have a look at previous stories:

Via Benzinga

Psychedelic Stock Gainers And Losers From November 22, 2022 ↗

November 22, 2022

Via Benzinga

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗

November 21, 2022

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

Via Benzinga

Psychedelic Stock Gainers And Losers From November 21, 2022 ↗

November 21, 2022

Via Benzinga

Psychedelic Drug Stocks Index Continued To Decline Last Week ↗

November 20, 2022

This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...

Via Talk Markets

Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

November 18, 2022

Via Benzinga

Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS' Published Results ↗

November 18, 2022

(Part two of a four-part series) See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

November 17, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From November 16, 2022 ↗

November 16, 2022

Via Benzinga

GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

November 15, 2022

Via Benzinga

Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗

November 14, 2022

We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...

Via Talk Markets

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.